Inspire Medical Systems Hits 52-Week Low at $39.29 Amidst Major Decline

Inspire Medical Systems, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 39.29 as of June 2, 2026. This significant drop highlights the company's struggles over the past year, with a performance decline of 74.79%, starkly contrasting with the S&P 500's gain of 28.2% during the same period. The company's market capitalization stands at USD 1,683 million, and it currently has a price-to-earnings (P/E) ratio of 11.00. Despite its low dividend yield of 0.00%, Inspire Medical Systems has reported a return on equity (ROE) of 19.13%, indicating some level of profitability. However, the stock's performance has been characterized by consistent underperformance against market benchmarks, with a notable decline of 28.74% in the last year alone. Inspire Medical Systems' price-to-book ratio is 2.15, reflecting its valuation in the market. The stock's previous 52-week high was USD 146.50, underscoring the extent of its recent decline. As the company navigates these challenges, its financial metrics will be closely monitored by market participants.